Monte Rosa Therapeutics, Inc. — All Filings
329 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001072613-26-000294 | Mar 19, 2026 | — |
| S-8 | S-8 | 0001193125-26-110712 | Mar 17, 2026 | — |
| 10-K | 10-K | 0001193125-26-109360 | Mar 17, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-109353 | Mar 17, 2026 | — |
| 4 | 4 | 0001193125-26-094296 | Mar 5, 2026 | Mar 4, 2026 |
| 4 | 4 | 0001193125-26-091733 | Mar 4, 2026 | Mar 2, 2026 |
| 144 | — | 0001193125-26-091704 | Mar 4, 2026 | — |
| 4 | 4 | 0001193125-26-085677 | Mar 2, 2026 | Feb 27, 2026 |
| 144 | — | 0001965301-26-000022 | Mar 2, 2026 | — |
| 144 | — | 0001950047-26-001966 | Mar 2, 2026 | — |
| 144 | — | 0001950047-26-001887 | Feb 27, 2026 | — |
| 4 | 4 | 0001193125-26-066955 | Feb 24, 2026 | Feb 23, 2026 |
| 144 | — | 0001950047-26-001676 | Feb 23, 2026 | — |
| SCHEDULE 13G/A | — | 0000921895-26-000461 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016412 | Feb 17, 2026 | — |
| S-3ASR | S-3ASR | 0001193125-26-046690 | Feb 11, 2026 | — |
| 8-K | 8-K | 0001193125-26-044616 | Feb 10, 2026 | Feb 9, 2026 |
| SCHEDULE 13G/A | — | 0001012975-26-000062 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001193125-26-009005 | Jan 9, 2026 | Jan 8, 2026 |
| 424B5 | 424B5 | 0001193125-26-009001 | Jan 9, 2026 | — |
| SCHEDULE 13D/A | — | 0001193125-26-008951 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-008902 | Jan 9, 2026 | Jan 7, 2026 |
| 144/A | — | 0001965301-26-000002 | Jan 8, 2026 | — |
| 144 | — | 0001965301-26-000001 | Jan 7, 2026 | — |
| 8-K | 8-K | 0001193125-26-006341 | Jan 7, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-006297 | Jan 7, 2026 | — |
| 8-K | 8-K | 0001193125-26-005420 | Jan 7, 2026 | — |
| 4 | 4 | 0001193125-26-002406 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-002401 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-002390 | Jan 5, 2026 | — |
| 4 | 4 | 0001193125-26-002389 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-002386 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-002385 | Jan 5, 2026 | Jan 2, 2026 |
| 144 | — | 0001193125-26-002369 | Jan 5, 2026 | — |
| 8-K | 8-K | 0001193125-25-319981 | Dec 16, 2025 | — |
| SCHEDULE 13G/A | — | 0000080255-25-000838 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004946 | Nov 14, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-277603 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-268045 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-268042 | Nov 6, 2025 | — |
| SCHEDULE 13G/A | — | 0000102909-25-000255 | Oct 31, 2025 | — |
| SCHEDULE 13G | — | 0001193125-25-242555 | Oct 17, 2025 | — |
| SCHEDULE 13G | — | 0001012975-25-000601 | Oct 3, 2025 | — |
| 8-K | 8-K | 0001193125-25-202760 | Sep 15, 2025 | — |
| UPLOAD | — | 0000000000-25-008933 | Aug 21, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003581 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-104550 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-104545 | Aug 7, 2025 | — |
| CORRESP | — | 0000950170-25-097510 | Jul 22, 2025 | — |
| UPLOAD | — | 0000000000-25-007429 | Jul 15, 2025 | — |